Palantir Co-Founder Joe Lonsdale Wants A FDA Overhaul With Special Forces-Style AI Team Because China Is Racing To Outpace US In Biotech

Why did Tesla stock drop after Musk’s political move? How will Trump’s new tariffs affect Asian markets? What’s driving CoreWeave’s $9B acquisition of Core Scientific? Why is Apple appealing its €500M EU fine? How is the Texas flood impacting local businesses? What caused Samsung’s profit to plunge this quarter? How are tariffs reshaping US-European trade relations?

Palantir Co-Founder Joe Lonsdale Wants A FDA Overhaul With Special Forces-Style AI Team Because China Is Racing To Outpace US In Biotech

benzinga.com/markets/biotech/25/07/46289610/palantir-co-founder-joe-lonsdale-wants-a-fda-overhaul-with-special-forces-style-ai-team-because-c

On Monday, Palantir Technologies Inc. (NASDAQ:PLTR) co-founder Joe Lonsdale urged a tech-driven transformation of the Food and Drug Administration, warning that bureaucratic inertia is putting the U.S. behind China in the biotech race.
What Happened: In a blog post, Lonsdale said the…

This story appeared on benzinga.com, 2025-07-08 06:41:07.